REYKJAVIK, Iceland, March 25 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN) today announced that it will host a live webcast of deCODE CEO Kari Stefansson's presentation at BioCentury 2008 Future Leaders in the Biotech Industry Conference.
The presentation will be delivered at 1:30 PM ET / 5:30 GMT on Thursday, March 27 at the Millennium Broadway Hotel & Conference Center, New York City. The webcast can be accessed through the Investors page on deCODE's website, http://www.decode.com/, and those interested in listening should log on a few minutes in advance in order to download any software or complete any sign-in that may be required. The webcast will be archived for at least one week.
About deCODE deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs and diagnostics for common diseases. deCODE is a global leader in gene discovery -- our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. deCODE is also leveraging its expertise in human genetics and integrated drug discovery and development capabilities to offer innovative products and services in personal genome analysis, DNA-based diagnostics, bioinformatics, genotyping, structural biology, drug discovery and clinical development. deCODE is delivering on the promise of the new genetics.(SM) Visit us on the web at http://www.decode.com/; on our diagnostics website at http://www.decodediagnostics.com/; and, for our pioneering personal genome analysis service, at http://www.decodeme.com/.
Contact:
deCODE genetics
Gisli Arnason
+354-570-1825
DATASOURCE: deCODE genetics CONTACT: Gisli Arnason of deCODE genetics, +354-570-1825, Web site: http://www.decode.com/ http://www.decodediagnostics.com/ http://www.decodeme.com/
|